Global Epiglottic Abscess Market, By Treatment (Vaccination, Medication, Supportive Care, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Epiglottic Abscess Market Analysis and Size
The epiglottic abscess market is expected to witness significant growth during the forecast period. Rising cases of common infectious such as haemophilus influenzae, streptococcus pneumonia, and respiratory tract viruses and increased use of hot drinks drives the epiglottic abscess market. Rising prevalence of respiratory disorders worldwide and emerging markets are the factors responsible for the growth of this market. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the epiglottic abscess market in the forecast period 2022-2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Epiglottic abscess is the rare sequelae of acute epiglottitis. It is the emergency medical condition, if it is not treated quickly it may result patient death. Epiglottitis is flap of tissues present on the base of tongue that keeps food from going into the trachea or windpipe during swallowing. When the tissue of epiglottis becomes infected or inflamed, this may lead to obstruction and close off the windpipe, which may be fatal unless promptly treated. Symptoms include difficulty swallowing, fast heart rate, sore throat, muffling, changes in the voice, difficulty speaking and fever. It is of great importance to the healthcare sector and thus is expected to rise high in the forecast period
Global Epiglottic Abscess Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Treatment (Vaccination, Medication, Supportive Care, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Pfizer Inc (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Mylan N.V. (U.S.), Fresenius Kabi AG (Germany), Hikma Pharmaceuticals PLC (U.K.), Novartis AG (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel), HEYER Medical AG (Germany), Smiths Medical, Inc (U.S.), Johnson & Johnson Services, Inc. (U.S.), Arbor Pharmaceuticals, Inc (U.S.)
|
|
Market Opportunities
|
Increased Incidence of Smoking
|
Global Epiglottic Abscess Market Dynamics
Drivers
- Increase in Respiratory Disorders
The rise in respiratory disorders is surely boosting the market growth. It is studied that around 545 million people in the world witnessed a respiratory disease in 2017 with an increase of 39·8% since 1990. This boost the market growth.
- Rising Demand for Oral Drugs
Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.
Opportunities
- Increased Incidence of Smoking
There is an estimated 30.8 million adults currently smoke cigarettes in the U.S. 90% of budding smokers become addicted at an young age, especially at the age of which leads to the increase in the incidence of smoking. Thus, it creates more opportunities in the future.
Restraints/Challenges
- Lack of Skilled Professionals
Lack of trained professionals who are unaware of the knowledge of the treatment methods for this disease could curb the growth of the global epiglottic abscess market over a forecast period.
- High Cost
The huge expenditure of the treatment methods surely hamper the market growth.
This epiglottic abscess market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global epiglottic abscess market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Epiglottic Abscess Market Scope
The epiglottic abscess market is segmented on the basis of treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment
- Vaccination
- Medication
- Supportive Care
- Others
Route of Administration
- Oral
- Parenteral
- Others
End-Users
- Hospitals
- Homecare
- Speciality Centres
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Epiglottic Abscess Market Regional Analysis/Insights
The global epiglottic abscess market is analysed and market size insights and trends are provided by treatment, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global epiglottic abscess market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific is expected to have the highest market growth due to rising adult population suffering from tracheal disorder, increased usage of cigarettes and presence of abundant generic manufacturers.
North America dominates the market due presence of advanced technology, increased usage of narcotic substance by adults and high R&D & healthcare expenditure.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Epiglottic Abscess Market Share Analysis
The global epiglottic abscess market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global epiglottic abscess market.
Key players operating in the global epiglottic abscess market include:
- Pfizer Inc (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Mylan N.V. (U.S.)
- Fresenius Kabi AG (Germany)
- Hikma Pharmaceuticals PLC (U.K.)
- Novartis AG (Switzerland)
- Teva Pharmaceutical Industries Ltd. (Israel)
- HEYER Medical AG (Germany)
- Smiths Medical, Inc (U.S.)
- Johnson & Johnson Services, Inc. (U.S.)
- Arbor Pharmaceuticals, Inc (U.S.)
SKU-